Naproxen Sodium is owned by Bionpharma Inc.
Naproxen Sodium contains Naproxen Sodium.
Naproxen Sodium has a total of 5 drug patents out of which 0 drug patents have expired.
Naproxen Sodium was authorised for market use on 17 February, 2006.
Naproxen Sodium is available in capsule;oral dosage forms.
Naproxen Sodium can be used as temporary relief of minor aches and pains; temporary reduction of fever.
The generics of Naproxen Sodium are possible to be released after 03 March, 2026.
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10028925 | BIONPHARMA INC | Liquid dosage forms of sodium naproxen |
Mar, 2026
(2 years from now) | |
US10022344 | BIONPHARMA INC | Liquid dosage forms of sodium naproxen |
Mar, 2026
(2 years from now) | |
US11090280 | BIONPHARMA INC | Liquid dosage forms of sodium naproxen |
Mar, 2026
(2 years from now) | |
US9693979 | BIONPHARMA INC | Liquid dosage forms of sodium naproxen |
Mar, 2026
(2 years from now) | |
US9693978 | BIONPHARMA INC | Solvent system for enhancing the solubility of pharmaceutical agents |
Mar, 2026
(2 years from now) |
Drugs and Companies using NAPROXEN SODIUM ingredient
Market Authorisation Date: 17 February, 2006
Treatment: Temporary relief of minor aches and pains; Temporary reduction of fever
Dosage: CAPSULE;ORAL
9
United States
2
China
2
European Union
1
Canada
1
Mexico
1
Cyprus
1
Slovenia
1
Denmark
1
Hungary
1
Portugal
1
Spain
1
Poland
1
Lithuania
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic